Treatment discovery and development
The company discovers, develops and commercializes treatments for under-addressed neurological, psychiatric, endocrine and immunological disorders.
Source: LinkedIn company description · Retrieved October 13, 2026
Company profileneurocrine.com ↗
Neurocrine Biosciences
Neurocrine Biosciences is a biopharmaceutical company focused on relieving suffering for people with significant needs.
- Headquarters
- San Diego, California, United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 1001 to 5000Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 1992Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 25 supported appearances ↗Source: RevenueBase lists
What does Neurocrine Biosciences do?
The company discovers, develops and commercializes treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. Its portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Services & capabilities.
Clinical-stage compounds
The pipeline includes multiple compounds in mid- to late-phase clinical development across the company's core therapeutic areas.
Source: LinkedIn company description · Retrieved October 13, 2026
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
#1OF 25
↗#1OF 12
↗#1OF 25
↗#1OF 25
↗#1OF 21
↗#1OF 25
↗#2OF 25
↗#2OF 25
↗#2OF 25
↗#2OF 25
↗#3OF 25
↗#3OF 25
↗#3OF 25
↗#4OF 25
↗#5OF 25
↗#5OF 25
↗#6OF 25
↗#7OF 25
↗#8OF 25
↗#15OF 25
↗#17OF 25
↗#18OF 25
↗#19OF 25
↗#20OF 25
↗#22OF 25
↗Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
BADGE PREVIEW
Open the published source list.
Open the published source list.Neurocrine Biosciences
#1 Drug development and research companies
Snapshot: September 18, 2026
Company information
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 29, 2026 and October 10, 2026. How the company lists are built.
Help keep this profile accurate
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Find your next account
Explore company profiles →One company is just the start.
Explore more companies by name, headquarters and business focus.